FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and is a pharmaceutical combination of 5HT1A agonist and 5HT3 antagonist for the treatment of alcohol dependence.
EFFECT: invention makes it possible to obtain a new preparation for reducing alcohol consumption by alcohol-dependent mammals.
9 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGONISM OF 5НТ-RECEPTOR FOR TREATMENT OF DISTURBANCE OF THERMOREGULATION FUNCTION | 2003 |
|
RU2340333C2 |
| PREPARATION AND METHOD FOR PRODUCING THE PREPARATION FOR TREATING ALCOHOLISM AND DRUG ADDICTION | 2003 |
|
RU2252756C1 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| SYNTHESIS AND USE OF TETRAHYDROPYROLLO[3,2-c]PYRIDIN-4-ONE DERIVATIVES TO TREAT OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2006 |
|
RU2415856C2 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| IMIDAZOLE DERIVATIVES ACTIVE TO CB1 RECEPTOR | 2005 |
|
RU2377238C2 |
| METHOD FOR REDUCTION OF MORBID ATTRACTION TO ETHANOL IN POSTABSTINENT PERIOD | 2007 |
|
RU2373927C2 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES | 2014 |
|
RU2679661C1 |
| DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ADDICTION IN HUMANS | 2012 |
|
RU2605283C2 |
